004720 — PharmGen Science Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual cashflow statement for PharmGen Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	11,209	41,949	89,960	7,991	1,017
Depreciation
Amortisation
Non-Cash Items	-6,230	-39,514	-80,051	-4,065	12,552
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-5,266	2,241	-14,522	-2,688	-15,776
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,676	7,784	-1,286	5,439	2,384
Capital Expenditures	-5,463	-34,010	-11,956	-3,292	-2,784
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-2,257	3,625	-3,328	6,552	1,894
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-7,721	-30,385	-15,284	3,260	-889
Financing Cash Flow Items	70	-176	1,803	297	270
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities	19,568	30,340	2,269	8,852	-484
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	14,523	7,739	-14,302	17,551	1,011